Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Implantable cardioverter defibrillator]

H Kasanuki1

  • 1Department of Cardiology, Heart Institute of Japan, Tokyo Women's Medical College.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|August 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Third heart sound in hospitalised patients with acute heart failure: insights from the ATTEND study.

International journal of clinical practice·2014
Same author

Sudden cardiac death and left ventricular ejection fraction during long-term follow-up after acute myocardial infarction in the primary percutaneous coronary intervention era: results from the HIJAMI-II registry.

Heart (British Cardiac Society)·2008
Same author

[Surgical treatment of Marfan syndrome; late results and new strategy].

Kyobu geka. The Japanese journal of thoracic surgery·2002
Same author

Role of desethylamiodarone in the anticoagulant effect of concurrent amiodarone and warfarin therapy.

Journal of cardiovascular pharmacology and therapeutics·2002
Same author

Retinoic acid suppresses endothelin-1 gene expression at the transcription level in endothelial cells.

Atherosclerosis·2001
Same author

Amiodarone-Induced thyroid dysfunction and ventricular tachyarrhythmias during long-term therapy in Japan.

Japanese circulation journal·2001

Implantable cardioverter-defibrillator (ICD) therapy prevents sudden cardiac death from ventricular tachycardia/fibrillation (VT/VF). Careful consideration of ICD indications and patient informed consent are crucial due to potential complications.

Area of Science:

  • Cardiology
  • Medical Devices
  • Electrophysiology

Context:

  • Implantable cardioverter-defibrillator (ICD) therapy is a critical intervention for preventing sudden cardiac death.
  • The adoption of ICDs has significantly increased globally since their introduction in the 1980s.
  • Japan's adoption and reimbursement of ICDs in the 1990s indicate growing acceptance and integration into healthcare systems.

Purpose:

  • To review the current status and future trends of ICD therapy.
  • To highlight the challenges and considerations associated with ICD implantation and management.
  • To emphasize the importance of patient selection and informed consent in ICD therapy.

Summary:

  • ICD therapy is primarily used as a last resort to prevent sudden cardiac death caused by ventricular tachycardia (VT) or ventricular fibrillation (VF).

Related Experiment Videos

  • Global use has surged since the 1980s, with significant adoption in Europe and the United States, followed by Japan in the 1990s.
  • Despite its efficacy, ICD therapy presents challenges including complications, inappropriate shocks, device limitations (size, longevity), and psychological impacts.

    • Impact:

    • ICD therapy remains a vital tool in managing life-threatening arrhythmias.
    • Careful consideration of patient indications for ICDs is essential to optimize outcomes.
    • Obtaining informed patient consent is paramount due to the inherent risks and complexities of ICD therapy.